Detection of markers predictive of macrolide and fluoroquinolone resistance in Mycoplasma genitalium from patients attending sexual health services in England

Objectives Resistance to both macrolides and fluoroquinolones has been reported in Mycoplasma genitalium; however, due to limited diagnostics, studies are often small and confined to specific geographical areas. This study sought to determine the rate of predicted resistance in M. genitalium-positive specimens referred for diagnostic testing. Methods Seventy-four M. genitalium-positive specimens, referred to the national reference laboratory (2010-2013) from 19 centres across England, were blinded and anonymised. Specimens were examined for markers predictive of resistance to macrolides and fluoroquinolones using PCR followed by sequence analysis of 23S rRNA gene, or gyrA and parC, respectively. Results 23S rRNA gene PCR sequencing revealed that 82.4% (61/74) of specimens harboured a single nucleotide polymorphism (SNP) associated with macrolide resistance. Differences were observed between the rates of predicted macrolide resistance in male (95.1% (58/61)) and female (23.1% (3/13)) patients (P = <0.001). By contrast, all specimens for which sequencing data were available (73/74) yielded wild-type gyrA sequences; and 58/61 (95.1%) had wild-type parC genes. Three specimens (3/61 4.9%) had SNPs in the parC gene associated with fluoroquinolone treatment failure, and all three also had predicted resistance to macrolides. Conclusions Eighty-two per cent and 4.9% of M. genitalium specimens had SNPs associated with macrolide and fluoroquinolone resistance, respectively. Due to lack of widespread availability of testing for M. genitalium in the UK, this study sample was likely to be sourced from patients who may have already failed first-line macrolide therapy. Nevertheless, this study highlights the need for both greater access to M. genitalium diagnostics and genetic antimicrobial resistance testing.

[1]  S. Nordbø,et al.  A Novel SimpleProbe PCR Assay for Detection of Mutations in the 23S rRNA Gene Associated with Macrolide Resistance in Mycoplasma genitalium in Clinical Samples , 2016, Journal of Clinical Microbiology.

[2]  D. Getman,et al.  Mycoplasma genitalium Prevalence, Coinfection, and Macrolide Antibiotic Resistance Frequency in a Multicenter Clinical Study Cohort in the United States , 2016, Journal of Clinical Microbiology.

[3]  S. Garland,et al.  Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology , 2016, PloS one.

[4]  R. Pitt,et al.  O031 Pelvic Inflammatory Disease (PID), Mycoplasma genitalium and macrolide resistance in England , 2016 .

[5]  K. Schønning,et al.  A 5′ Nuclease Genotyping Assay for Identification of Macrolide-Resistant Mycoplasma genitalium in Clinical Specimens , 2016, Journal of Clinical Microbiology.

[6]  V. Allen,et al.  Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance. , 2016, Canadian family physician Medecin de famille canadien.

[7]  P. Muir,et al.  2015 UK National Guideline on the management of non-gonococcal urethritis , 2016, International journal of STD & AIDS.

[8]  A. Rowhani-Rahbar,et al.  Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  S. Garland,et al.  Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  J. Jensen,et al.  Direct Detection of Macrolide Resistance in Mycoplasma genitalium Isolates from Clinical Specimens from France by Use of Real-Time PCR and Melting Curve Analysis , 2014, Journal of Clinical Microbiology.

[11]  E. Adams,et al.  Time to manage Mycoplasma genitalium as an STI: but not with azithromycin 1 g! , 2014, Current opinion in infectious diseases.

[12]  C. Carder,et al.  A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London , 2014, BMJ Open.

[13]  A. Witney,et al.  High Prevalence of Antibiotic-Resistant Mycoplasma genitalium in Nongonococcal Urethritis: The Need for Routine Testing and the Inadequacy of Current Treatment Options , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  G. Gilbert,et al.  Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance , 2013, International journal of STD & AIDS.

[15]  L. Meyn,et al.  O04.6  Mycoplasma Genitalium- Is It a Pathogen in Acute Pelvic Inflammatory Disease (PID)? , 2013, Sexually Transmitted Infections.

[16]  M. Golden,et al.  O02.3 Treatment Outcomes For Persistent Mycoplasma Genitalium-Associated NGU: Evidence of Moxifloxacin Treatment Failures , 2013, Sexually Transmitted Infections.

[17]  G. Gilbert,et al.  Fluoroquinolone and Macrolide Resistance-Associated Mutations in Mycoplasma genitalium , 2013, Journal of Clinical Microbiology.

[18]  J. Jensen,et al.  Treatment of Mycoplasma genitalium. Observations from a Swedish STD Clinic , 2013, PloS one.

[19]  Liang Ma,et al.  Persistent Mycoplasma genitalium Infection of Human Endocervical Epithelial Cells Elicits Chronic Inflammatory Cytokine Secretion , 2012, Infection and Immunity.

[20]  S. Osser,et al.  Mycoplasma genitalium in cervicitis and pelvic inflammatory disease among women at a gynecologic outpatient service. , 2012, American journal of obstetrics and gynecology.

[21]  S. Garland,et al.  Transmission and Selection of Macrolide Resistant Mycoplasma genitalium Infections Detected by Rapid High Resolution Melt Analysis , 2012, PloS one.

[22]  M. Golden,et al.  Mycoplasma genitalium: should we treat and how? , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  D. Taylor-Robinson,et al.  Mycoplasma genitalium: from Chrysalis to Multicolored Butterfly , 2011, Clinical Microbiology Reviews.

[24]  M. Yasuda,et al.  Selection of Mycoplasma genitalium strains harbouring macrolide resistance-associated 23S rRNA mutations by treatment with a single 1 g dose of azithromycin , 2011, Sexually Transmitted Infections.

[25]  C. Mcgowin,et al.  Mycoplasma genitalium: An Emerging Cause of Sexually Transmitted Disease in Women , 2011, PLoS pathogens.

[26]  S. Garland,et al.  'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women.' , 2011, BMC infectious diseases.

[27]  L. Lopez,et al.  Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  M. Yasuda,et al.  Macrolide resistance-associated 23S rRNA mutation in Mycoplasma genitalium, Japan. , 2011, Emerging infectious diseases.

[29]  R. Kerani,et al.  Comprehensive Assessment of Sociodemographic and Behavioral Risk Factors for Mycoplasma genitalium Infection in Women , 2010, Sexually transmitted diseases.

[30]  S. Kerry,et al.  Is Mycoplasma genitalium in women the "New Chlamydia?" A community-based prospective cohort study. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  M. Yasuda,et al.  Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance. , 2010, International journal of antimicrobial agents.

[32]  S. Tabrizi,et al.  Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  J. Jensen,et al.  Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial , 2007, Sexually Transmitted Infections.

[34]  K. Holmes,et al.  Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection. , 2007, American journal of public health.

[35]  F. Olesen,et al.  Mycoplasma genitalium: prevalence and behavioural risk factors in the general population , 2006, Sexually Transmitted Infections.

[36]  P. Horner,et al.  Mycoplasma genitalium is associated with symptomatic urethritis , 2006, International journal of STD & AIDS.

[37]  J. Jensen,et al.  Use of TaqMan 5′ Nuclease Real-Time PCR for Quantitative Detection of Mycoplasma genitalium DNA in Males with and without Urethritis Who Were Attendees at a Sexually Transmitted Disease Clinic , 2004, Journal of Clinical Microbiology.

[38]  M. Egger,et al.  Do all men attending departments of genitourinary medicine need to be screened for non-gonococcal urethritis? , 2002, International journal of STD & AIDS.

[39]  S. Thompson,et al.  Acute pelvic inflammatory disease. , 1977, Sexually transmitted diseases.